RYMAX (RYMAX) Stock Price & Analysis
RYMAX (RYMAX) fell 0.40% to USD 70.18 as of July 26, 2026 at 00:44 UTC, according to Nexqual real-time market data.
RYMAX last closed at USD 70.46; the session ranged USD 70.18–70.18 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 48.69–82.66 (NAS). Source: Nexqual, July 26, 2026 at 00:44 UTC.
Key Statistics (as of July 26, 2026 at 00:44 UTC)
| Price | USD 70.18 |
|---|---|
| Change | ▼ 0.40% (down) |
| Previous Close | USD 70.46 |
| Open | USD 70.18 |
| Day Range | USD 70.18 – 70.18 |
| 52-Week Range | USD 48.69 – 82.66 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (RYMAX)
Nexqual's technical model rates RYMAX "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 26, 2026 at 00:44 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 38.84 (neutral) |
| vs SMA50 | Below (USD 75.01) |
| MACD | -1.17 (negative) |
Financial Health Score (RYMAX)
Nexqual rates RYMAX's overall financial health "Mixed" across five dimensions, as of July 26, 2026 at 00:44 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RYTAX | Rydex Series Fds, Technology Fu | USD 271.81 | ▼ 2.72% |
| RYKAX | Rydex Series Fds, Banking Fund | USD 116.67 | ▼ 0.34% |
| RYHAX | Rydex Series Fds, Health Care F | USD 122.53 | ▲ 1.36% |
| RYOAX | Rydex Series Fds, Biotechnology | USD 67.96 | ▲ 0.53% |
| RYCAX | Rydex Series Fds, Consumer Prod | USD 96.51 | ▼ 1.01% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 00:44 UTC. This page is informational and not investment advice.